Skip to main content

Animations

MJFF Publications

251 - 260 of 8808 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2023
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2021
  • 2022
  • Summary Details
    RESTRICTED
    Title: Environmental neurotoxicants and inflammasome activation in Parkinson’s disease – A focus on the gut-brain axis
    Journal Name: The International Journal of Biochemistry & Cell Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.biocel.2021.106113
    Citation Count: 8
  • Summary Details
    RESTRICTED
    Title: Mechanisms of NLRP3 activation and pathology during neurodegeneration
    Journal Name: The International Journal of Biochemistry & Cell Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.biocel.2022.106273
    Citation Count: 10
  • Summary Details
    RESTRICTED
    Title: Strategies for quantifying the enzymatic activities of glycoside hydrolases within cells and in vivo
    Journal Name: Current Opinion in Chemical Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.cbpa.2023.102403
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Orthostatic Hypotension in Parkinson Disease
    Journal Name: Clinics in Geriatric Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.cger.2019.09.002
    Citation Count: 48
  • Summary Details
    RESTRICTED
    Title: Pharmacokinetic profile of the selective 5-HT3 receptor antagonist ondansetron in the rat: an original study and a minireview of the behavioural pharmacological literature in the rat
    Journal Name: Canadian Journal of Physiology and Pharmacology
    Publisher: Canadian Science Publishing
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1139/cjpp-2019-0551
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Recent Advances on Graph Analytics and Its Applications in Healthcare
    Journal Name: Proceedings of the 26th ACM SIGKDD International Conference on Knowledge Discovery & Data Mining
    Publisher: ACM
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1145/3394486.3406469
    Citation Count: 9
  • Summary Details
    RESTRICTED
    Title: Initiation of pharmacological therapy in Parkinson's disease: when, why, and how
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30036-3
    Citation Count: 121
  • Summary Details
    RESTRICTED
    Title: Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30314-8
    Citation Count: 283
  • Summary Details
    RESTRICTED
    Title: Progress towards therapies for disease modification in Parkinson's disease
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00061-2
    Citation Count: 157
  • Summary Details
    RESTRICTED
    Title: A biological classification of Huntington's disease: the Integrated Staging System
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00120-x
    Citation Count: 86
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.